Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Treasury Shares (2023 - 2025)

Historic Treasury Shares for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $722086.0.

  • Rallybio's Treasury Shares fell 2981.56% to $722086.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $722086.0, marking a year-over-year decrease of 2981.56%. This contributed to the annual value of $1.1 million for FY2024, which is 20043.99% up from last year.
  • As of Q3 2025, Rallybio's Treasury Shares stood at $722086.0, which was down 2981.56% from $1.2 million recorded in Q2 2025.
  • Over the past 5 years, Rallybio's Treasury Shares peaked at $1.4 million during Q1 2025, and registered a low of $354394.0 during Q4 2023.
  • For the 3-year period, Rallybio's Treasury Shares averaged around $755856.6, with its median value being $703881.0 (2023).
  • As far as peak fluctuations go, Rallybio's Treasury Shares tumbled by 4262.17% in 2024, and later surged by 24084.68% in 2025.
  • Quarter analysis of 3 years shows Rallybio's Treasury Shares stood at $354394.0 in 2023, then skyrocketed by 200.44% to $1.1 million in 2024, then tumbled by 32.18% to $722086.0 in 2025.
  • Its last three reported values are $722086.0 in Q3 2025, $1.2 million for Q2 2025, and $1.4 million during Q1 2025.